Human papillomavirus (HPV) vaccines
Loading...
Date
Authors
Visser, Adele
Hoosen, Anwar Ahmed
Journal Title
Journal ISSN
Volume Title
Publisher
Health and Medical Publishing Group
Abstract
Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries. In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66 - 69 years. With the development of prophylactic HPV
vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications.
Description
Keywords
Human papillomavirus vaccine
Sustainable Development Goals
Citation
Visser, A & Hoosen, A 2012, 'Human papillomavirus (HPV) vaccines', CME : Continuing Medical Education, vol. 30, no. 1, pp. 29.